PetIQ, Inc. (PETQ) Misses Q4 EPS by 51c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
PetIQ, Inc. Reports Record Fourth Quarter and Full Year 2021 Financial Results
March 1, 2022 4:05 PM ESTReports Fourth Quarter Net Sales of $196.6 Million and Full Year Net Sales of $932.5 Million
Company Provides First Quarter 2022 and Full Year 2022 Outlook
EAGLE, Idaho, March 01, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the fourth quarter and full year ended December 31, 2021.
Cord Christensen, PetIQs Chairman & CEO commented, We are very pleased with our strong finish to 2021. Our record fourth quarter was better than we expected driven by... More
